Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.28 EX-10.28
- 14.1 EX-14.1
- 23.2 EX-23.2
Associated filings
- 16 Oct 20 424B4 Prospectus supplement with pricing info
- 16 Oct 20 EFFECT Notice of effectiveness
- 6 Oct 20 FWP Free writing prospectus
- 6 Oct 20 S-1/A IPO registration (amended)
- 3 Sep 20 S-1/A IPO registration (amended)
- 24 Aug 20 FWP Free writing prospectus
- 24 Aug 20 S-1/A IPO registration (amended)
- 5 Aug 20 FWP Free writing prospectus
- 5 Aug 20 S-1/A IPO registration (amended)
- 21 Jul 20 FWP Free writing prospectus
- 13 Jul 20 S-1/A IPO registration (amended)
- 26 Jun 20 S-1/A IPO registration (amended)
-
11 May 20 S-1 IPO registration
KRBP similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on FormS-1 of our report dated April 6, 2020 relating to the financial statements of Kiromic BioPharma, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Houston, Texas
May 11, 2020